GRI Bio Inc expected to post a loss of 73 cents a share - Earnings Preview

GRI Bio

08/11/2024 22:30

* GRI Bio Inc  GRI.OQ   GRI.O  is expected to report
resultson
November 12 (estimated) for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for GRI Bio Inc is for a
loss
of 73 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "Buy".​
    * Wall Street's median 12-month price target for GRI Bio Inc
is
$12.00​, above​ its last closing price of $0.88. ​​​

This summary was machine generated November 8 at 22:30 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)